Toripalimab in Combination With R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma
- Diffuse Large B Cell Lymphoma
- EBV-Positive DLBCL, Nos
- Follicular Lymphoma Grade IIIb
- High Grade B Cell Lymphoma
- Transformed Lymphoma
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 60 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04058470
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon